The hardest part of AI patient matching often begins after the system identifies a possible participant.

That match still has to reach the right coordinator, survive a detailed chart review, fit the site’s current capacity, and lead to an appropriate conversation with the patient. When those steps remain disconnected, better matching can simply produce a longer list for site staff to manage.

Effective AI patient matching must support the entire recruitment pathway. That means connecting patient data, eligibility review, clinical judgment, referral, outreach, screening, and follow-up in a workflow that sites can realistically use.

What Does AI Patient Matching Need to Accomplish?

AI patient matching tools are designed to compare available patient information with clinical trial eligibility criteria. Depending on the system and data available, they may analyze diagnoses, laboratory results, treatment histories, disease characteristics, medications, clinical notes, and other relevant information.

The immediate output is usually a list of patients who may qualify for a study. That list can help coordinators focus their time, particularly when manual chart review would require searching through hundreds or thousands of records.

However, identifying a potential match is only one step. A useful system must also help the site understand:

• Why the patient was identified
• Which criteria appear to be satisfied
• Which criteria remain uncertain
• What information is missing
• How urgently the record should be reviewed
• What action should happen next

These details turn an algorithmic result into something a research team can evaluate and use.

Why Is Match Accuracy Only One Measure of Success?

Accuracy matters, but it does not provide a complete picture of operational value.

A matching tool may identify a high percentage of potentially eligible patients while creating too many false positives for coordinators to review efficiently. Another system may produce a smaller, more precise group but miss patients whose eligibility information appears only in unstructured notes.

Sites also need to know whether potential matches can move through the recruitment process. A technically accurate result creates limited value if the patient has already changed treatment, lives too far from the site, cannot meet the visit schedule, or never reaches the staff responsible for outreach.

A more practical evaluation should follow patients through the full workflow. Relevant measures include:

• Number of records reviewed
• Time required for chart review
• Percentage of matches confirmed by site staff
• Patients contacted or referred
• Patients who consent to screening
• Screen failure rates
• Patients ultimately enrolled
• Staff time required per enrolled participant

These measures help determine whether AI is improving recruitment rather than simply producing more candidates.

How Should AI Connect to Site Data?

Patient matching is only as current and complete as the information it can access. Sites may hold relevant data across electronic health records, laboratory systems, pathology reports, imaging records, referral platforms, and clinical research systems.

Requiring staff to export information manually can weaken the value of automation. It creates extra work, delays analysis, and increases the risk that the matching system will operate on incomplete or outdated records.

Integration does not necessarily require every source to be combined in a new central database. Different organizations may use direct system connections, secure data environments, or federated approaches that allow analysis to occur where the data already resides.

The right architecture depends on local systems, privacy requirements, institutional policies, and the intended use of the results. The practical objective remains consistent: matching should occur close enough to the source data to remain timely without creating another administrative process for the site.

Can Patient Matching Work Without Moving Sensitive Data?

Federated approaches can allow matching models to analyze data within a hospital, health system, or research network without transferring the underlying patient records to a central repository.

This can help organizations address privacy, security, and data-governance concerns while still using information from multiple locations. It may also make participation more practical for sites that cannot or will not move patient-level data outside their existing environment.

Federated technology does not remove every implementation challenge. Participating organizations still need compatible data definitions, reliable system connections, clear access controls, and agreement about how results will be reviewed and used.

The workflow must also specify what leaves the local environment. A site may permit the system to produce an internal list for authorized staff while limiting the information shared with sponsors or external partners. Making these rules explicit is essential for trust and responsible use.

Where Should Coordinators Enter the Process?

Research coordinators understand details that matching systems may not capture. They know whether a patient is already being considered for another study, whether an investigator believes the trial is clinically appropriate, and whether the site has the capacity to conduct screening within the required timeframe.

AI should help coordinators spend less time searching for possible patients and more time evaluating promising candidates. A practical workflow may begin with the system identifying and prioritizing records, followed by a coordinator reviewing the evidence behind each result.

The interface should make that review faster. Coordinators should be able to see the relevant criteria, supporting patient information, uncertain fields, and source records without moving through several disconnected systems.

They should also be able to record why a proposed match was accepted or rejected. That feedback provides valuable evidence for improving the matching process and understanding where eligibility criteria create recurring difficulties.

How Should Complex Eligibility Criteria Be Handled?

Clinical trial eligibility criteria are not always easy to translate into structured rules. Some depend on timing, prior therapies, disease progression, combinations of laboratory values, or clinical judgment. Others may be written in language that remains open to interpretation until a specific patient record is reviewed.

A patient matching system should clearly distinguish between confirmed information and inference. If the available data does not establish whether a criterion has been met, the system should flag that uncertainty for review instead of presenting the patient as definitively eligible.

Traceability is especially important. Site staff should be able to understand which data led to the recommendation and return to the original source when necessary.

Human review remains essential before outreach, referral, or enrollment decisions. AI can narrow the search and organize the evidence, while qualified clinical and research staff determine whether the study is appropriate for the individual patient.

What Happens After a Possible Match Is Identified?

A match needs a defined destination. Without clear routing, alerts may sit in an inbox, reach staff who cannot act on them, or arrive after the relevant enrollment window has passed.

Before implementation, the site and sponsor should define:

• Who receives new matches
• How quickly records should be reviewed
• Who confirms clinical suitability
• How treating physicians are involved
• Who is permitted to contact the patient
• How outreach attempts are recorded
• How declined participation and screen failures are documented
• How urgent or time-sensitive matches are escalated

These decisions should reflect the site’s existing referral and recruitment practices. Some organizations may route matches through a centralized research office. Others may rely on disease-specific coordinators, investigators, or treating physicians.

The technology should adapt to those differences. Requiring every site to adopt the same workflow can create resistance and reduce use, even when the underlying matching model performs well.

Why Does Site-Specific Configuration Matter?

Sites differ in staffing, systems, patient populations, referral pathways, and research experience. They may also interpret operational responsibilities differently, particularly around chart review and patient contact.

Implementation should therefore begin with an understanding of how recruitment currently works at each site. Teams need to identify where patient searches occur, which steps consume the most time, where potential participants are lost, and who has authority to take action.

Configuration may include study prioritization, alert frequency, user roles, review queues, escalation rules, and the amount of evidence displayed with each match. Training should be based on the tasks each user must perform rather than a general tour of the platform.

This local work takes time, but it determines whether the system becomes part of daily operations or remains an occasional tool used only by a few enthusiastic staff members.

How Can the Workflow Improve Over Time?

Every reviewed match creates feedback. False positives can reveal gaps in the available data or problems translating eligibility criteria. Missed patients may show that important information is buried in unstructured records. Screen failures may expose differences between apparent eligibility and the requirements applied during formal screening.

Sites and sponsors should review these outcomes regularly. The purpose is to improve both the matching model and the surrounding process.

A useful feedback loop may examine:

• Why proposed matches were rejected
• Which eligibility criteria generated the most uncertainty
• Where coordinators needed additional information
• Which patients could not be reached
• Why interested patients failed screening
• How long each stage of review required
• Whether certain sites or studies need different configurations

This analysis can also inform future protocol design. If matching repeatedly shows that a criterion eliminates a large portion of otherwise appropriate patients, study teams can assess whether that restriction is scientifically necessary in later trials.

Build AI Patient Matching Around the Work

AI patient matching can reduce manual chart review, help sites identify overlooked candidates, and connect more patients with relevant clinical trials. Those benefits depend on what happens after the algorithm produces a result.

The strongest implementations begin with the site workflow. They connect to current data, show the reasoning behind each match, route candidates to people who can act, preserve clinical oversight, and learn from recruitment outcomes.

That approach also provides a more meaningful standard for success. The goal is not to create the longest possible list of eligible patients. The goal is to help research teams move appropriate patients from identification to an informed opportunity to participate.

Continue the Conversation at SCOPE Summit Europe

AI-enabled patient matching, recruitment strategy, site workflows, and the responsible use of clinical data will be important areas of discussion at SCOPE Summit Europe. Leaders from across clinical research will explore practical ways to integrate new technology into trial operations and improve how studies identify, reach, and enroll participants.

Learn more and register here.